How MRI and CT predict flap failure after head and neck reconstructive cancer surgery

The findings could help shorten hospital stays for cancer patients.

5:00 AM

Author | Noah Fromson

MRI perfusion flap scan highlight
A composite picture from MR perfusion of a free flap demonstrating measurements made within the flap. Credit: Michigan Medicine

When a patient with head and neck cancer has surgery to remove it, they often need reconstructive surgery in the form of a "free flap", which is skin and tissue taken from a different part of the body and connected to the blood vessels of the wound in need of repair.

This free flap method, called microvascular reconstruction, carries around a 10-40% risk of wound complications, with 10% of cases requiring another surgery. A Michigan Medicine study finds that early postoperative CT scans and MRIs can help predict whether a flap will fail, which could allow surgeons to intervene earlier. The results are published in the American Journal of Neuroradiology.

MORE FROM THE LAB: Subscribe to our weekly newsletter

"All patients who have this procedure can be investigated with non-invasive post-operative CT or MRI perfusion, and these two methods show a lot of promise as accurate biomarkers of predicting free flap viability," said Ashok Srinivasan, M.D., FACR, senior author of the paper and neuroradiologist at University of Michigan Health.

SEE ALSO: Axitinib Improves Survival for Patients with Incurable Head and Neck Cancer

"By seeing how much blood is flowing in and out of the tissue, we may be able to predict if the flap will succeed and if the patient can be discharged earlier, or it may be able to tell us sooner that surgical intervention is needed to repair the flap. Radiologists have used CT and MRI perfusion with contrast to look at blood perfusion in brain imaging for a stroke or tumor, but no studies have used them to look at free flaps early after a procedure."

The U-M Head and Neck Oncology Program performs approximately 300 free flaps a year, with each of these patients staying approximately one week in the hospital after surgery. The ability to predict which patients are safe for an earlier discharge would have significant and immediate cost savings, says Matthew Spector, M.D., co-author of the paper and otolaryngologist at U-M Health. 

Currently, most surgeons use ultrasound to assess viability for free flap reconstruction with techniques known as doppler and skin paddle. Those methods often are unable to evaluate deeper aspects of the flap, or air and blood products cause interference in visualization, which affects how well clinicians can analyze a flap's viability, says Srinivasan, who is also a clinical professor of radiology at U-M Medical School.

SEE ALSO: HPV Fuels Uptick in Head and Neck Cancers in Taiwan, Study Finds

The team of researchers analyzed 19 patients who had successful free flap reconstruction, as well as five who had wound failure, at U-M Health between January 2016 to mid-2018. They found that both CT and MRI perfusion techniques showed significant differences between the two patient groups.

Researchers were not able to compare the two methods to ultrasound techniques or each other due to the small sample size. They hope to accomplish those comparisons through a larger future trial.

"This pilot research shows us that these models work, as all areas of the flap can be assessed using CT and MRI, unlike doppler and skin paddle where some areas may be blind to evaluation," said Yoshiaki Ota, M.D., lead author of the paper and a neuroradiology fellow at University of Michigan Health. "We know that using CT and MRI could help shorten a patient's hospital stay or avoid a prolonged hospitalization, and now we need to look further at which is more effective and cost-effective."

Additional authors include: Keith Casper, M.D., Chaz Stucken, M.D., Kelly Malloy, M.D., Remy Lobo, M.D., Akira Baba, M.D., Ph.D., all of Michigan Medicine, and Andreea Moore, M.D., Western Michigan University School of Medicine.

This work received funding from the American Society of Head and Neck Radiology under the William N. Hanafee, M.D., Research Grant and from the Internal Seed Grant of the Department of Radiology at the University of Michigan.

Paper cited: "Prediction of Wound Failure in Patients with Head and Neck Cancer Treated with Free Flap Reconstruction: Utility of CT Perfusion and MR Perfusion in the Early Postoperative Period," American Journal of Neuroradiology. DOI: 10.3174/ajnr.A7458

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Like Podcasts? Add the Michigan Medicine News Break on iTunes or anywhere you listen to podcasts.


More Articles About:

Body Work Head and Neck Cancer Cancer Surgery Cancer Treatment Computed Tomography Scan (CT) Magnetic Resonance Imaging (MRI) Ultrasound Cancer: Cancer Types
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Three people stand arm in arm with backs to camera studying a wall of family mementos
Health Lab

Online resources and coaching helped people seek genetic testing for cancer

New study from researchers at the University of Michigan Rogel Cancer Center showed an online resource and phone-based coaching both helped increase rates of genetic testing.
Health Lab

Liver cancer can be preventable. Do you know the treatable risk factors?

Learn about the risks of chronic liver disease, the treatable liver disease factors and how rates of liver cancer have increased.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast

PMOS is the New PCOS

What the shift from PCOS to PMOS means for your fertility journey.
Zhen Xu, the Li Ka Shing Professor of Biomedical Engineering, a professor of radiology and neurosurgery, and a co-inventor of histotripsy, speaks at the ribbon cutting for the U-M Histotripsy Center.
News Release

Histotripsy research center launches to advance sound-wave-based cancer treatment

Expanding use of a non-invasive, ultrasound-based cancer treatment is the ultimate goal of the new University of Michigan Histotripsy Center, a first-of-its-kind facility launched Sept. 10.
Health Lab

Prostate cancer and hereditary risk: A doctor explains the connection

Some genetic mutations linked to breast cancer also can affect men, but in a different way. A Michigan Medicine urologist explains the connection.
cancer cell floating with yellow dots drawn out blue
Health Lab

Biomarkers aid cost-benefit analysis of head and neck cancer immunotherapy

The cost-effectiveness of the immunotherapy drug pembrolizumab for patients with locally advanced head and neck squamous cell carcinoma may depend on biomarker results, according to a new study by Michigan Medicine.